Daiwa Securities Group Inc.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
1,307
Total Value
15007955
Accession Number
0001481045-25-000006
Form Type
13F-HR
Manager Name
Daiwa Securities Group Inc.
Data Enrichment
93% identified
1,218 identified89 unidentified

Holdings

1,307 positions
Manager:
Search and click to pin securities to the top
Page 64 of 64
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Shares:
909(+0.0%)
Value:
$1.0K(-50.0%)
CorMedix Inc.
Shares:
200(+0.0%)
Value:
$1.0K(-50.0%)
Neumora Therapeutics, Inc.
Shares:
533(+0.0%)
Value:
$1.0K(-83.3%)
ALUMIS INC.
Shares:
156(+0.0%)
Value:
$1.0K(+0.0%)
Sana Biotechnology, Inc.
Shares:
767(+0.0%)
Value:
$1.0K(+0.0%)
ACELYRIN, Inc.
Shares:
398(+0.0%)
Value:
$1.0K(+0.0%)
CODEXIS, INC.
Shares:
269(+0.0%)
Value:
$1.0K(+0.0%)
Relay Therapeutics, Inc.
Shares:
486(+0.0%)
Value:
$1.0K(-50.0%)
Olema Pharmaceuticals, Inc.
Shares:
224(+0.0%)
Value:
$1.0K(+0.0%)
Astria Therapeutics, Inc.
Shares:
186(+0.0%)
Value:
$1.0K(-50.0%)
Rapport Therapeutics, Inc.
Shares:
121(+0.0%)
Value:
$1.0K(-50.0%)
Biomea Fusion, Inc.
Shares:
109(+0.0%)
Value:
$0
Tango Therapeutics, Inc.
Shares:
355(+0.0%)
Value:
$0(-100.0%)
Lyell Immunopharma, Inc.
Shares:
917(+0.0%)
Value:
$0(-100.0%)
MACROGENICS INC
Shares:
209(+0.0%)
Value:
$0(-100.0%)
Terns Pharmaceuticals, Inc.
Shares:
151(+0.0%)
Value:
$0(-100.0%)
Alector, Inc.
Shares:
277(+0.0%)
Value:
$0(-100.0%)
Editas Medicine, Inc.
Shares:
277(+0.0%)
Value:
$0
PLIANT THERAPEUTICS, INC.
Shares:
196(+0.0%)
Value:
$0(-100.0%)